Medicare Enrolled
Dr. Erin Fleener, M.D.
Hematology & Oncology · Bryan, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fleener from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fleener? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fleener
Dr. Erin Fleener is a hematology & oncology in Bryan, TX, with 19 years in practice. Based on federal Medicare data, Dr. Fleener performed 153,105 Medicare services across 2,917 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fleener received a total of $11,809 from 88 pharmaceutical and/or device companies across 424 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fleener is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 2% volume in TX$ $11,809 industry payments
Medicare Practice Summary
Medicare Utilization ↗153,105
Medicare services
Top 2% in TX for hematology & oncology
2,917
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,058 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 23,460 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 20,700 | $43 | $100 |
| Oxaliplatin chemotherapy injection | 19,870 | $0 | $5 |
| Iron infusion (Injectafer) | 18,750 | $1 | $2 |
| Paclitaxel chemotherapy injection | 12,574 | $0 | $10 |
| Epoetin alfa injection (Procrit) for anemia | 9,800 | $6 | $30 |
| Denosumab injection (Prolia/Xgeva) | 8,580 | $18 | $45 |
| Injection, eflapegrastim-xnst, 0.1 mg | 6,336 | $25 | $50 |
| Dexamethasone injection (steroid) | 4,844 | $0 | $32 |
| Anti-nausea injection (fosaprepitant) | 4,800 | $0 | $3 |
| Epoetin alfa injection (Retacrit) for anemia | 3,320 | $6 | $20 |
| Blood draw (venipuncture) | 2,092 | $8 | $16 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,010 | $1 | $55 |
| Injection, fluorouracil, 500 mg | 1,689 | $2 | $7 |
| Complete blood count (CBC) with differential | 1,636 | $8 | $65 |
| Anti-nausea injection (ondansetron/Zofran) | 1,549 | $0 | $15 |
| Injection, leucovorin calcium, per 50 mg | 1,397 | $3 | $20 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 831 | $22 | $100 |
| Office visit, established patient (30-39 min) | 817 | $90 | $180 |
| Administration of chemotherapy into vein, 1 hour or less | 752 | $100 | $300 |
| Injection, irinotecan, 20 mg | 643 | $2 | $60 |
| Office visit, established patient, complex (40-54 min) | 617 | $137 | $250 |
| Drug injection, under skin or into muscle | 597 | $11 | $100 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 572 | $3 | $30 |
| Injection, carboplatin, 50 mg | 548 | $2 | $115 |
| Injection, potassium chloride, per 2 meq | 490 | $0 | $2 |
| Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | 480 | $96 | $575 |
| Injection, atropine sulfate, 0.01 mg | 450 | $0 | $1 |
| Administration of additional new drug or substance into vein, 1 hour or less | 438 | $50 | $240 |
| Administration of chemotherapy into vein, each additional hour | 291 | $21 | $140 |
| Injection of additional new drug or substance into vein | 241 | $12 | $60 |
| Office visit, established patient (20-29 min) | 235 | $59 | $125 |
| Infusion, normal saline solution , 1000 cc | 212 | $2 | $18 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 179 | $47 | $150 |
| Injection, diphenhydramine hcl, up to 50 mg | 166 | $1 | $20 |
| Injection, zoledronic acid, 1 mg | 160 | $6 | $170 |
| Administration of prolonged chemotherapy into vein | 150 | $98 | $300 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 120 | $1 | $240 |
| Infusion into a vein for hydration, 31-60 minutes | 114 | $25 | $90 |
| Irrigation of implanted venous access drug delivery device | 98 | $19 | $90 |
| New patient office visit, complex (60-74 min) | 84 | $168 | $350 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 82 | $21 | $250 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 69 | $56 | $180 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 68 | $15 | $80 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 54 | $1 | $15 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 48 | $390 | $800 |
| Infusion into a vein for hydration, each additional hour | 37 | $10 | $115 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 23 | $20 | $30 |
| Flu vaccine administration | 20 | $30 | $52 |
| New patient office visit (45-59 min) | 12 | $119 | $275 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
28.5% high complexity
67.5% medium
4.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,809
Total received (2018-2024)
Avg $1,687/year across 7 years
Top 29% in TX for hematology & oncology
88
Companies
424
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,134 (85.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$983 (8.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$379 (3.2%)
Other
Charitable contributions, space rental, and other categories
$312 (2.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,557
2023$1,879
2022$1,406
2021$1,642
2020$570
2019$1,567
2018$2,188
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,532
Janssen Biotech, Inc.
$841
Novartis Pharmaceuticals Corporation
$747
E.R. Squibb & Sons, L.L.C.
$578
Amgen Inc.
$479
Incyte Corporation
$449
Helsinn Therapeutics (U.S.), Inc.
$408
GlaxoSmithKline, LLC.
$339
Lilly USA, LLC
$339
Ipsen Biopharmaceuticals, Inc
$325
Genentech USA, Inc.
$315
PFIZER INC.
$281
Merck Sharp & Dohme Corporation
$271
Celgene Corporation
$241
Myriad Genetic Laboratories, Inc.
$234
Daiichi Sankyo Inc.
$229
Astellas Pharma US Inc
$209
Takeda Pharmaceuticals U.S.A., Inc.
$208
Taiho Oncology, Inc.
$179
Merck Sharp & Dohme LLC
$141
Tactile Systems Technology Inc
$129
Boehringer Ingelheim Pharmaceuticals, Inc.
$122
GENZYME CORPORATION
$118
Eisai Inc.
$112
Dendreon Pharmaceuticals LLC
$112
INTUITIVE SURGICAL, INC.
$111
Coherus Biosciences Inc.
$103
ARRAY BIOPHARMA INC
$103
Gilead Sciences, Inc.
$103
Seagen Inc.
$98
ASD SPECIALTY HEALTHCARE, LLC
$97
Stemline Therapeutics Inc.
$91
TerSera Therapeutics LLC
$91
Tempus AI, Inc
$85
Amneal Pharmaceuticals LLC
$85
MorphoSys, US Inc.
$76
Deciphera Pharmaceuticals Inc.
$74
BeiGene USA, Inc.
$72
Pharmacyclics LLC, An AbbVie Company
$71
EMD Serono, Inc.
$70
Regeneron Healthcare Solutions, Inc.
$64
Foundation Medicine, Inc.
$61
Clovis Oncology, Inc.
$61
TESARO, Inc.
$60
Karyopharm Therapeutics Inc.
$56
ABBVIE INC.
$55
Spectrum Pharmaceuticals Inc.
$55
IntrinsiQ Specialty Solutions, Inc.
$54
PUMA BIOTECHNOLOGY, INC.
$54
Octapharma USA, Inc.
$53
Genmab U.S., Inc.
$46
Pharmacosmos Therapeutics Inc.
$46
AMAG Pharmaceuticals, Inc.
$46
Mirati Therapeutics, Inc.
$41
TAIHO ONCOLOGY, INC.
$41
Janssen Pharmaceuticals, Inc
$40
EISAI INC.
$39
Seattle Genetics, Inc.
$34
Tolmar, Inc.
$33
Iovance Biotherapeutics, Inc.
$31
SpringWorks Therapeutics, Inc.
$29
Verity Pharmaceuticals Inc.
$28
AVEO Pharmaceuticals, Inc.
$27
Immunocore Limited
$26
ImmunoGen, Inc.
$26
PharmaEssentia USA Corporation
$26
Celltrion USA Inc.
$25
Teva Pharmaceuticals USA, Inc.
$24
Agios Pharmaceuticals, Inc.
$23
JAZZ PHARMACEUTICALS INC.
$22
Puma Biotechnology, Inc.
$21
AbbVie Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
SOBI, INC
$20
Novocure Inc.
$20
Blueprint Medicines Corporation
$19
Aveo Pharmaceuticals, Inc.
$19
Acceleron Pharma, Inc.
$19
Epizyme, Inc.,
$19
ADMA BioManufacturing LLC
$19
SERVIER PHARMACEUTICALS LLC
$18
Rigel Pharmaceuticals, Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
Heron Therapeutics, Inc.
$14
TOLMAR Pharmaceuticals, Inc.
$14
ADC Therapeutics America, Inc.
$13
EAGLE PHARMACEUTICALS, INC.
$13
Acrotech Biopharma LLC
$12
Top 3 companies account for 26.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALIMTA · Alecensa · Aliqopa · Amtagvi · Avastin · BELEODAQ · BELRAPZO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CALQUENCE · CINVANTI · COSELA · CYRAMZA · Columvi · DARZALEX · DOPTELET · Da Vinci Surgical System · ELIGARD · ELIQUIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Elahere · Enhertu · Epkinly · Erleada · FERAHEME · FLEXITOUCH · FOTIVDA · FOUNDATIONFOCUS · FOUNDATIONONE · FRUZAQLA · Flexitouch Plus · GAVRETO · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUMIZYME · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONIVYDE · ONUREG · OPDIVO · OPDUALAG · Oncology · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PREVNAR 13 · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · PreciseTumor · QINLOCK · REBLOZYL · ROLVEDON · Reblozyl · Revlimid · Rituxan Hycela · Rubraca · SCEMBLIX · SOMATULINE DEPOT · SUTENT · Somatuline Depot · TAGRISSO · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TRUSELTIQ · TUKYSA · Tavalisse · Trelstar · Trodelvy · Udenyca · VEGZELMA · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xospata · Xtandi · ZEJULA · ZOLADEX · Zoladex · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $8 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
7
Per 100K population
2.9
County median income
$58,388
Nearest hospital
CHI ST JOSEPH HEALTH REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Fleener is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Fleener experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Fleener performed 23,460 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fleener receive payments from pharmaceutical companies?
Yes. Dr. Fleener received a total of $11,809 from 88 companies across 424 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fleener's costs compare to other hematology & oncologys in Bryan?
Dr. Fleener's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fleener) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Bryan
Browse hematology & oncologys in Bryan ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology